Form 4: Teladoc Health Executive Vidya Raman-Tangella Acquires 35,000 Restricted Stock Units

Vidya Raman-Tangella, Chief Medical Officer of Teladoc Health, acquired 35,000 restricted stock units on March 19, 2024.

Summary

• On March 19, 2024, Vidya Raman-Tangella, the Chief Medical Officer of Teladoc Health, acquired 35,000 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Teladoc Health common stock.
• The RSUs vest over time, with one-third vesting on the first anniversary of the grant date.
• The remaining RSUs vest in eight substantially equal quarterly installments starting on June 1, 2025.
• Following the transaction, Raman-Tangella directly owns 35,000 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider stock transactions, which is neutral in sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings of company stock.

Stakeholder Impact

• The acquisition of restricted stock units by a key executive could be viewed positively by shareholders, as it aligns the executive's interests with the company's long-term performance.

Key Dates